COMMUNIQUÉS West-GlobeNewswire

Orion Biotechnology Canada report that IND- enabling studies evaluating the safety of their OB-002H microbicide gel have shown an excellent mucosal safety profile

29/01/2019 - 14:58

OTTAWA, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced preclinical data evaluating the safety of OB-002H (5P12-RANTES) which is being [...]

Arch Biopartners Closes Convertible Note Financing

29/01/2019 - 14:46

TORONTO, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced it has closed the non-brokered, unsecured convertible note (“Note”) financing [...]

Marrone Bio Innovations to Host Virtual Roadshow Webinar on February 12th at 8:30 a.m. Pacific Time

29/01/2019 - 14:31

DAVIS, Calif., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (the “Company” or “MBI”) (NASDAQ: MBII ), an international leader in smart biopesticide and plant health solutions, today announced that it [...]

Menlo Therapeutics Announces Late-Breaking Oral Presentation at the American Academy of Dermatology Annual Meeting

29/01/2019 - 14:30

Results from the Phase 2 Clinical Trial of Serlopitant to Treat Pruritus with Psoriasis to be Presented on March 2, 2019 REDWOOD CITY, Calif., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a [...]

ProQR Announces “ProQR Vision 2023” Strategy at its Annual R&D Day

29/01/2019 - 14:30

LEIDEN, the Netherlands & CAMBRIDGE, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines, today [...]

OLAH Healthcare Technology names Gregory Miller as Chief Executive Officer

29/01/2019 - 14:18

COLUMBUS, Ohio, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Tim Vogel, chairman of the Board of Directors of OLAH Healthcare Technology, announced the appointment of Gregory Miller as OLAH’s new chief executive officer effective [...]

Dr. Eric Simpson to Present Bermekimab Results in Atopic Dermatitis at 2019 AAD Annual Meeting

29/01/2019 - 14:15

Bermekimab Rapidly Treats Atopic Dermatitis While Reducing Itch and Pain AUSTIN, Texas, Jan. 29, 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today that findings from its open label, multicenter study [...]

Extendicare Announces Timing of 2018 Fourth Quarter and Year End Results and Conference Call

29/01/2019 - 14:13

MARKHAM, Ontario, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the fourth quarter and year ended [...]

Momenta Pharmaceuticals Announces First Subject Dosed in Phase 1/2 Clinical Trial of M254, Hypersialylated Immunoglobulin G

29/01/2019 - 14:00

CAMBRIDGE, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated [...]

Oryzon to present at upcoming international conferences

29/01/2019 - 14:00

21 st Annual BIO CEO & Investor Conference 2019 in New York, USA 12 th Annual European Life Sciences CEO Forum in Zurich, Switzerland 2019 BioCapital Europe in Amsterdam, The Netherlands 31 st Annual ROTH Conference [...]

Allakos Announces Positive Phase 2 Results in Patients with Cholinergic Urticaria and Symptomatic Dermographism

29/01/2019 - 14:00

-- 82% (9 of 11) response rate in patients with cholinergic urticaria -- -- 70% (7 of 10) response rate in patients with symptomatic dermographism -- REDWOOD CITY, Calif., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Allakos Inc [...]

Samumed to Present Novel Biological Targets of SM04690 for Treatment of Knee Osteoarthritis

29/01/2019 - 14:00

Study results highlight novel drug discovery targets for the treatment of knee osteoarthritis Company to present data in late-breaking poster at Orthopaedic Research Society (ORS) 2019 Annual Meeting SAN DIEGO, Jan. 29 [...]

Spero Therapeutics Announces Initiation of SPR720 Phase 1 Clinical Trial

29/01/2019 - 14:00

CAMBRIDGE, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments [...]

scPharmaceuticals Inc. Announces Development Agreement with West Pharmaceutical Services for Next-Generation FUROSCIX® On-Body Infusor

29/01/2019 - 14:00

Advancing FUROSCIX ® with the SmartDose ® Drug Delivery System Forecast 2018 year-end cash of $82 - $87 million and 2019 expenditures of $8 - $10 million per quarter BURLINGTON, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- [...]

BrainsWay Receives PMDA Approval in Japan of Deep Transcranial Magnetic Stimulation System for Treatment of Major Depressive Disorder

29/01/2019 - 14:00

Approval allows BrainsWay’s Deep TMS System to be marketed throughout Japan JERUSALEM, Jan. 29, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (TASE: BRIN) , a global leader in the advanced non-invasive treatment of brain [...]

Altimmune Announces Presentation of HepTcell Phase 1 Results at The International Liver Congress™ in Vienna, Austria

29/01/2019 - 14:00

GAITHERSBURG, Md., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced results of its recently completed HepTcell Phase 1 clinical trial will be [...]

Precipio Gains Recognition on NY Radio Station WHPC Show “My Hometown” As Innovator Battling Cancer Misdiagnosis

29/01/2019 - 13:47

CEO Ilan Danieli discusses the importance of obtaining an accurate diagnosis, and the challenges patients and physicians face NEW HAVEN, Conn., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company [...]

Auris Medical to Redomicile Holding Company from Switzerland to Bermuda

29/01/2019 - 13:31

Move to Bermuda will enhance corporate flexibility, reduce costs and provide better alignment with U.S. corporate law Subject to approval by extraordinary general meeting of shareholders Zug, Switzerland, January 29, [...]

KemPharm Announces Enhancements to U.S. and Global Intellectual Property Estate

29/01/2019 - 13:30

Patents Extend Across KemPharm’s Prodrug Portfolio, Including IP Protection for KP415 in Canada, Japan and Korea CELEBRATION, Fla., Jan. 29, 2019 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty [...]